ID21924A - Olanzapin dihidrat d - Google Patents

Olanzapin dihidrat d

Info

Publication number: ID21924A
Authority: ID; Indonesia
Prior art keywords: dihidrat; olanzapin; benzodiazepine; thieno; methyl
Prior art date: 1996-09-23

Application number

IDW990059A

Other languages

English (en)

Inventor

Samuel Dean Larsen

John Richard Nichols

Susan Marie Reutzel

Gregory Alan Stephenson

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-23

Filing date

1997-09-18

Publication date

1999-08-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21924(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-09-18 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-08-12 Publication of ID21924A publication Critical patent/ID21924A/id

Links

KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title 1
KHXIELCFAHVRAL-UHFFFAOYSA-N 2-methylthieno[2,3-i][1,2]benzodiazepine Chemical compound C12=NN(C)C=CC=C2C=CC2=C1C=CS2 KHXIELCFAHVRAL-UHFFFAOYSA-N 0.000 abstract 1
150000004683 dihydrates Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IDW990059A 1996-09-23 1997-09-18 Olanzapin dihidrat d ID21924A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2648696P	1996-09-23	1996-09-23

Publications (1)

Publication Number	Publication Date
ID21924A true ID21924A (id)	1999-08-12

Family

ID=21832112

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW990059A ID21924A (id)	1996-09-23	1997-09-18	Olanzapin dihidrat d

Country Status (34)

Country	Link
US (1)	US6251895B1 (id)
EP (1)	EP0831097B1 (id)
JP (1)	JP2001500878A (id)
KR (1)	KR100516088B1 (id)
CN (1)	CN1146567C (id)
AR (1)	AR009801A1 (id)
AT (1)	ATE221074T1 (id)
AU (1)	AU720366B2 (id)
BR (1)	BR9711541A (id)
CA (1)	CA2266444C (id)
CO (1)	CO4900057A1 (id)
CZ (1)	CZ299247B6 (id)
DE (1)	DE69714165T2 (id)
DK (1)	DK0831097T3 (id)
EA (1)	EA001881B1 (id)
EG (1)	EG23815A (id)
ES (1)	ES2180899T3 (id)
HU (1)	HU226167B1 (id)
ID (1)	ID21924A (id)
IL (1)	IL128956A0 (id)
MY (1)	MY125467A (id)
NO (1)	NO323979B1 (id)
NZ (1)	NZ334346A (id)
PE (1)	PE110298A1 (id)
PL (1)	PL194074B1 (id)
PT (1)	PT831097E (id)
RS (1)	RS49597B (id)
SI (1)	SI0831097T1 (id)
SV (1)	SV1997000079A (id)
TR (1)	TR199900639T2 (id)
TW (1)	TW518335B (id)
UA (1)	UA56184C2 (id)
WO (1)	WO1998011893A1 (id)
ZA (1)	ZA978512B (id)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA978515B (en) *	1996-09-23	1999-03-23	Lilly Co Eli	Intermediates and process for preparing olanzapine
US6617321B2 (en)	1997-09-30	2003-09-09	Eli Lilly And Company	2-methyl-thieno-benzodiazepine formulation
EP1119359B1 (en) *	1998-09-30	2004-05-26	Eli Lilly & Company	2-methyl-thieno-benzodiazepine formulation
CA2395774C (en) *	1999-12-28	2009-09-15	Cipla Limited	New polymorphic forms of olanzapine
US7022698B2 (en)	1999-12-28	2006-04-04	U & I Pharmaceuticals, Ltd.	Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
IL154688A0 (en) *	2000-08-31	2003-09-17	Reddys Lab Ltd Dr	Hydrates of olanzapine and processes for the preparation thereof
US6740753B2 (en)	2001-01-04	2004-05-25	Geneva Pharmaceuticals, Inc.	Olanzapine crystal modification
WO2003037903A1 (en) *	2001-10-29	2003-05-08	Dr. Reddy's Laboratories Ltd.	Olanzapine dihydrate-ii a process for its preparation and use thereof
DE60336226D1 (de)	2002-05-31	2011-04-14	Sandoz Ag	Verfahren zur herstellung von olanzapin form i
SI21270A (sl)	2002-07-15	2004-02-29	Krka, Tovarna Zdravil, D.D., Novo Mesto	Kristalne oblike olanzapina in postopki za njihovo pripravo
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2004058773A1 (en) *	2002-12-24	2004-07-15	Teva Pharmaceutical Industries Ltd.	Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
US6861422B2 (en)	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
EP1684734A2 (en) *	2003-11-18	2006-08-02	3M Innovative Properties Company	Olanzapine containing transdermal drug delivery compositions
EP1709053B1 (en)	2004-01-27	2011-04-06	Synthon B.V.	Stable salts of olanzapine
DE102004029784A1 (de)	2004-06-21	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de)	2004-06-24	2006-01-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20080009481A1 (en) *	2004-07-14	2008-01-10	Shasun Chemicals And Drugs Limited	Process For Making Form I Of Olanzapine
US7728134B2 (en)	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060074088A1 (en)	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
EP1630163A1 (de)	2004-08-25	2006-03-01	Boehringer Ingelheim Pharma GmbH & Co.KG	Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2303462B1 (es)	2004-09-06	2009-06-05	Shasun Chemicals And Drugs Limited	Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
KR101381454B1 (ko)	2004-09-29	2014-04-04	바이엘 인텔렉쳐 프로퍼티 게엠베하	열역학적으로 안정한 형태의 ｂａｙ 43-9006 토실레이트
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
US7910577B2 (en) *	2004-11-16	2011-03-22	Elan Pharma International Limited	Injectable nanoparticulate olanzapine formulations
DE102004058337A1 (de)	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
PL1838716T3 (pl)	2005-01-05	2011-09-30	Lilly Co Eli	Dihydrat embonianu olanzapiny
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
WO2007067714A2 (en) *	2005-12-08	2007-06-14	The Mclean Hospital Corporation	Treatment of sequelae of psychiatric disorders
US7834176B2 (en) *	2006-01-26	2010-11-16	Sandoz Ag	Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
US7439358B2 (en)	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
PE20110235A1 (es)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
MX2008014024A (es)	2006-05-04	2008-11-14	Boehringer Ingelheim Int	Formas poliformas.
AR062927A1 (es)	2006-10-11	2008-12-17	Bayer Healthcare Ag	4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
US8039461B1 (en)	2006-11-10	2011-10-18	Pisgah Laboratories, Inc.	Physical states of a pharmaceutical drug substance
US7718649B1 (en)	2006-11-10	2010-05-18	Pisgah Labs, Inc.	Physical states of a pharmaceutical drug substance
EP2185559A1 (en)	2007-08-03	2010-05-19	Boehringer Ingelheim International GmbH	Crystalline form of a dihydropteridione derivative
PE20140960A1 (es)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
US8883863B1 (en)	2008-04-03	2014-11-11	Pisgah Laboratories, Inc.	Safety of psuedoephedrine drug products
EP2299983A4 (en) *	2008-07-24	2012-10-10	Handa Pharmaceuticals Llc	ATYPICAL ANTIPSYCHOTIC FORMULATION STABILIZED
KR20200118243A (ko)	2008-08-06	2020-10-14	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
CN102149407A (zh)	2008-09-10	2011-08-10	贝林格尔.英格海姆国际有限公司	治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh)	2008-12-23	2017-08-04	勃林格殷格翰国际有限公司	有机化合物的盐形式
TW201036975A (en)	2009-01-07	2010-10-16	Boehringer Ingelheim Int	Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EP2504002B1 (en)	2009-11-27	2019-10-09	Boehringer Ingelheim International GmbH	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
KR101927068B1 (ko)	2010-05-05	2018-12-10	베링거 인겔하임 인터내셔날 게엠베하	체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
KR20200028498A (ko)	2010-06-24	2020-03-16	베링거 인겔하임 인터내셔날 게엠베하	당뇨병 요법
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
HUE061596T2 (hu)	2011-07-15	2023-07-28	Boehringer Ingelheim Int	Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US20130303462A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es)	2012-05-14	2022-11-24	Boehringer Ingelheim Int	Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
JP2016027003A (ja) *	2012-11-20	2016-02-18	大蔵製薬株式会社	長期間安定なオランザピンの水性医薬製剤
WO2015011236A1 (en)	2013-07-26	2015-01-29	Boehringer Ingelheim International Gmbh	Treatment of myelodysplastic syndrome
EP3110449B1 (en)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medical use of a dpp-4 inhibitor
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
BR112018072401A2 (pt)	2016-06-10	2019-02-19	Boehringer Ingelheim International Gmbh	combinações de linagliptina e metformina

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5302716A (en) *	1986-01-16	1994-04-12	Schering Corporation	Fused benzazepines
GB9009229D0 (en) *	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
EP0582368B1 (en) *	1992-05-29	2001-01-24	Eli Lilly And Company Limited	Thienobenzodiazepine derivatives for treatment of CNS disorders
NZ289619A (en)	1994-06-28	1998-12-23	Grace W R & Co	Bag with patches, the patches having overhang regions which are adhered together
EG24221A (en) *	1995-03-24	2008-11-10	Lilly Co Eli	Process for preparing olanzapine
EP0733368A1 (en) *	1995-03-24	1996-09-25	Eli Lilly And Company	Granule fomulation for olanzapine
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) *	1995-03-24	1997-05-20	Eli Lilly And Company	Process and solvate of 2-methyl-thieno-benzodiazepine

1997
- 1997-09-18 HU HU0000065A patent/HU226167B1/hu not_active IP Right Cessation
- 1997-09-18 WO PCT/US1997/016586 patent/WO1998011893A1/en not_active Ceased
- 1997-09-18 BR BR9711541A patent/BR9711541A/pt not_active IP Right Cessation
- 1997-09-18 NZ NZ334346A patent/NZ334346A/en not_active IP Right Cessation
- 1997-09-18 CA CA002266444A patent/CA2266444C/en not_active Expired - Fee Related
- 1997-09-18 IL IL12895697A patent/IL128956A0/xx not_active IP Right Cessation
- 1997-09-18 EA EA199900325A patent/EA001881B1/ru not_active IP Right Cessation
- 1997-09-18 JP JP10514881A patent/JP2001500878A/ja not_active Withdrawn
- 1997-09-18 AU AU44241/97A patent/AU720366B2/en not_active Ceased
- 1997-09-18 UA UA99031634A patent/UA56184C2/uk unknown
- 1997-09-18 PL PL97332541A patent/PL194074B1/pl unknown
- 1997-09-18 ID IDW990059A patent/ID21924A/id unknown
- 1997-09-18 KR KR10-1999-7002423A patent/KR100516088B1/ko not_active Expired - Fee Related
- 1997-09-18 TR TR1999/00639T patent/TR199900639T2/xx unknown
- 1997-09-18 RS YUP-154/99A patent/RS49597B/sr unknown
- 1997-09-18 CZ CZ0098999A patent/CZ299247B6/cs not_active IP Right Cessation
- 1997-09-18 CN CNB971981213A patent/CN1146567C/zh not_active Expired - Fee Related
- 1997-09-22 ES ES97307379T patent/ES2180899T3/es not_active Expired - Lifetime
- 1997-09-22 EP EP97307379A patent/EP0831097B1/en not_active Expired - Lifetime
- 1997-09-22 ZA ZA978512A patent/ZA978512B/xx unknown
- 1997-09-22 CO CO97055058A patent/CO4900057A1/es unknown
- 1997-09-22 MY MYPI97004393A patent/MY125467A/en unknown
- 1997-09-22 DK DK97307379T patent/DK0831097T3/da active
- 1997-09-22 DE DE69714165T patent/DE69714165T2/de not_active Expired - Lifetime
- 1997-09-22 AT AT97307379T patent/ATE221074T1/de active
- 1997-09-22 SI SI9730408T patent/SI0831097T1/xx unknown
- 1997-09-22 SV SV1997000079A patent/SV1997000079A/es active IP Right Grant
- 1997-09-22 PT PT97307379T patent/PT831097E/pt unknown
- 1997-09-23 PE PE1997000853A patent/PE110298A1/es not_active Application Discontinuation
- 1997-09-23 US US08/935,883 patent/US6251895B1/en not_active Expired - Fee Related
- 1997-09-23 EG EG98597A patent/EG23815A/xx active
- 1997-09-23 AR ARP970104361A patent/AR009801A1/es not_active Application Discontinuation
1998
- 1998-02-27 TW TW086113833A patent/TW518335B/zh not_active IP Right Cessation
1999
- 1999-03-19 NO NO19991339A patent/NO323979B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EA001881B1 (ru)	2001-10-22
CO4900057A1 (es)	2000-03-27
NO323979B1 (no)	2007-07-30
PT831097E (pt)	2002-10-31
JP2001500878A (ja)	2001-01-23
EP0831097A3 (en)	1998-04-29
EG23815A (en)	2007-08-19
SI0831097T1 (en)	2003-02-28
CZ98999A3 (cs)	1999-08-11
HU226167B1 (hu)	2008-05-28
TW518335B (en)	2003-01-21
ATE221074T1 (de)	2002-08-15
DE69714165T2 (de)	2003-01-23
CA2266444A1 (en)	1998-03-26
KR100516088B1 (ko)	2005-09-22
EP0831097A2 (en)	1998-03-25
EP0831097B1 (en)	2002-07-24
MY125467A (en)	2006-08-30
DK0831097T3 (da)	2002-09-02
PE110298A1 (es)	1999-01-18
CN1234738A (zh)	1999-11-10
NO991339L (no)	1999-03-19
PL332541A1 (en)	1999-09-13
IL128956A0 (en)	2000-02-17
CN1146567C (zh)	2004-04-21
AR009801A1 (es)	2000-05-03
HUP0000065A3 (en)	2000-11-28
CA2266444C (en)	2007-01-09
KR20000048519A (ko)	2000-07-25
ZA978512B (en)	1999-03-23
TR199900639T2 (xx)	1999-06-21
US6251895B1 (en)	2001-06-26
AU4424197A (en)	1998-04-14
HUP0000065A2 (hu)	2000-06-28
RS49597B (sr)	2007-06-04
CZ299247B6 (cs)	2008-05-28
NZ334346A (en)	2000-05-26
UA56184C2 (uk)	2003-05-15
SV1997000079A (es)	1999-01-13
DE69714165D1 (de)	2002-08-29
WO1998011893A1 (en)	1998-03-26
EA199900325A1 (ru)	1999-08-26
NO991339D0 (no)	1999-03-19
BR9711541A (pt)	1999-08-24
HK1009809A1 (en)	1999-06-11
AU720366B2 (en)	2000-06-01
PL194074B1 (pl)	2007-04-30
ES2180899T3 (es)	2003-02-16
YU15499A (sh)	2000-03-21

Publication	Publication Date	Title
ID21924A (id)	1999-08-12	Olanzapin dihidrat d
DK1489082T3 (da)	2013-12-09	Mellemprodukter
FI960631A0 (fi)	1996-02-12	Termostabiilit ksylanaasit
DE69708409D1 (de)	2002-01-03	Messwertgeber
DE59709549D1 (de)	2003-04-24	Vormischbrenner
EP0621686A3 (en)	1995-10-18	Amplifier.
DZ1835A1 (fr)	2002-02-17	Nouvelles formulations.
DE59610190D1 (de)	2003-04-10	Vormischbrenner
DE59610441D1 (de)	2003-06-18	Vormischbrenner
DE69712037D1 (de)	2002-05-23	Mischkopfdüse
DE59406607D1 (de)	1998-09-10	Konstantstromquelle
FR2703904B1 (fr)	1995-06-09	Prothèse trapézo-métacarpienne.
MA23303A1 (fr)	1995-04-01	6-fluoroalkyluraciles-1-substitues-3-(bicycliques heterocyclyles.)
ES1027324Y (es)	1995-02-16	Soplador
YU48719B (sh)	1999-07-28	Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida
ES1025316Y (es)	1994-07-01	Ambientador mejorado.
ES1024481Y (es)	1994-08-01	Canape desmontable.
FR2715459B3 (fr)	1995-12-22	Brûleur atmosphérique.
ES1033367Y (es)	1997-01-01	Colgante oerfeccionado.
BR7601539U (pt)	1998-08-11	Régua-gabarito
BR9602954A (pt)	1998-04-28	Régua gabarito
ES1024801Y (es)	1994-05-01	Abanico informativo-publicitario.
FR2715023B1 (fr)	1996-03-01	Dérouleuse - pailleuse.
ES1029889Y (es)	1996-01-01	Baliza aerostatica perfeccionada.
ES1024260Y (es)	1994-04-01	Abanico.